CIK 0001070081
- Large accelerated filer
PTC THERAPEUTICS, INC.
Sign in to watch- Ticker
- PTCT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 043416587
- Phone
- +1 908-222-7000
- Business address
- 500 WARREN CORPORATE CENTER DRIVE, WARREN, NJ, 07059
- Former names
- PTC THERAPEUTICS INC
- 4 Open-market sale Director sold 510 shares at $38.53 ($19,648)
- 4 Grant or award Director acquired 6,400 shares (grant or award)
- 4 Grant or award Director acquired 3,200 shares (grant or award)
- 4 Grant or award Director acquired 3,200 shares (grant or award)
- 4 Grant or award Director acquired 3,200 shares (grant or award)
- 4 Grant or award Director acquired 3,200 shares (grant or award)
- 4 Grant or award Director acquired 3,200 shares (grant or award)
- 4 Grant or award Director acquired 3,200 shares (grant or award)
- 4 Open-market sale Chief Technical Ops Officer sold 64 shares at $41.16 ($2,634)
- 4 Open-market sale Chief Financial Officer sold 173 shares at $41.16 ($7,121)
- 4 Open-market sale Chief Business Officer sold 806 shares at $41.16 ($33,177)
- 4 Open-market sale Chief Executive Officer sold 378 shares at $41.16 ($15,559)
- 4 Open-market sale Exec. VP and CLO sold 3,363 shares at $45.01 ($151,375)
- 4 Open-market sale Director sold 1,650 shares at $40.06 ($66,094)
- 4 Open-market sale Exec. VP and CLO sold 9,234 shares at an average $45.19 ($417,274)
- 4 Grant or award Director acquired 2,613 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Chief Executive Officer acquired 6,240 shares (grant or award)
- 4 Open-market sale Director sold 365 shares at $41.89 ($15,288)
- 4 Open-market sale Chief Business Officer sold 786 shares at $48.17 ($37,860)
Page 15 of 31 · 618 filings